Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-002262
Filing Date
2023-07-05
Accepted
2023-07-05 17:10:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2903
  Complete submission text file 0001959173-23-002262.txt   4245
Mailing Address 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142
Business Address
Requadt Scott (Reporting) CIK: 0001664852 (see all company filings)

Type: 144

Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Subject) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40384 | Film No.: 231070487
SIC: 2836 Biological Products, (No Diagnostic Substances)